These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22340708)

  • 21. Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease.
    Watt AD; Perez KA; Faux NG; Pike KE; Rowe CC; Bourgeat P; Salvado O; Masters CL; Villemagne VL; Barnham KJ
    J Alzheimers Dis; 2011; 24(1):47-59. PubMed ID: 21157020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies.
    Luo X; Hou L; Shi H; Zhong X; Zhang Y; Zheng D; Tan Y; Hu G; Mu N; Chan J; Chen X; Fang Y; Wu F; He H; Ning Y
    J Neurochem; 2013 Dec; 127(5):681-90. PubMed ID: 23800322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of soluble receptor for advanced glycation end products in Alzheimer's disease.
    Xu XY; Deng CQ; Wang J; Deng XJ; Xiao Q; Li Y; He Q; Fan WH; Quan FY; Zhu YP; Cheng P; Chen GJ
    Int J Neurosci; 2017 May; 127(5):454-458. PubMed ID: 27323891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
    Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
    Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Mitochondrial Quality Control Related Biomarker Levels are Associated with Organ Dysfunction in Septic Patients.
    Huang W; Wang X; Zhang H; Wang G; Xie F; Liu D
    Shock; 2021 Sep; 56(3):412-418. PubMed ID: 33534397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of Blood Thiamine Metabolites for Alzheimer's Disease Diagnosis.
    Pan X; Fei G; Lu J; Jin L; Pan S; Chen Z; Wang C; Sang S; Liu H; Hu W; Zhang H; Wang H; Wang Z; Tan Q; Qin Y; Zhang Q; Xie X; Ji Y; Cui D; Gu X; Xu J; Yu Y; Zhong C
    EBioMedicine; 2016 Jan; 3():155-162. PubMed ID: 26870826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADAM10 as a biomarker for Alzheimer's disease: a study with Brazilian elderly.
    Manzine PR; de França Bram JM; Barham EJ; do Vale Fde A; Selistre-de-Araújo HS; Cominetti MR; Iost Pavarini SC
    Dement Geriatr Cogn Disord; 2013; 35(1-2):58-66. PubMed ID: 23306532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic utility of VEGF and soluble CD40L levels in serum of Alzheimer's patients.
    Yu S; Liu YP; Liu YH; Jiao SS; Liu L; Wang YJ; Fu WL
    Clin Chim Acta; 2016 Jan; 453():154-9. PubMed ID: 26706786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivariate analysis of differential lymphocyte cell cycle activity in Alzheimer's disease.
    Stieler J; Grimes R; Weber D; Gartner W; Sabbagh M; Arendt T
    Neurobiol Aging; 2012 Feb; 33(2):234-41. PubMed ID: 20395014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional Analysis of Blood Lymphocytes and Skin Fibroblasts, Keratinocytes, and Endothelial Cells as a Potential Biomarker for Alzheimer's Disease.
    Mukhamedyarov MA; Rizvanov AA; Yakupov EZ; Zefirov AL; Kiyasov AP; Reis HJ; Teixeira AL; Vieira LB; Lima LM; Salafutdinov II; Petukhova EO; Khaiboullina SF; Schlauch KA; Lombardi VC; Palotás A
    J Alzheimers Dis; 2016 Oct; 54(4):1373-1383. PubMed ID: 27589530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer's disease.
    Janel N; Alexopoulos P; Badel A; Lamari F; Camproux AC; Lagarde J; Simon S; Feraudet-Tarisse C; Lamourette P; Arbones M; Paul JL; Dubois B; Potier MC; Sarazin M; Delabar JM
    Transl Psychiatry; 2017 Jun; 7(6):e1154. PubMed ID: 28632203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose-6-phosphate dehydrogenase a novel hope on a blood-based diagnosis of Alzheimer's disease.
    Evlice A; Ulusu NN
    Acta Neurol Belg; 2017 Mar; 117(1):229-234. PubMed ID: 27378307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cofilin 2 in Serum as a Novel Biomarker for Alzheimer's Disease in Han Chinese.
    Sun Y; Liang L; Dong M; Li C; Liu Z; Gao H
    Front Aging Neurosci; 2019; 11():214. PubMed ID: 31447667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vibrational spectroscopic analysis of peripheral blood plasma of patients with Alzheimer's disease.
    Carmona P; Molina M; López-Tobar E; Toledano A
    Anal Bioanal Chem; 2015 Oct; 407(25):7747-56. PubMed ID: 26255297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infrared spectroscopic analysis of mononuclear leukocytes in peripheral blood from Alzheimer's disease patients.
    Carmona P; Molina M; Calero M; Bermejo-Pareja F; Martínez-Martín P; Alvarez I; Toledano A
    Anal Bioanal Chem; 2012 Feb; 402(6):2015-21. PubMed ID: 22271100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial dynamics and biogenesis indicators may serve as potential biomarkers for diagnosis of myasthenia gravis.
    Li L; Cai D; Zhong H; Liu F; Jiang Q; Liang J; Li P; Song Y; Ji A; Jiao W; Song J; Li J; Chen Z; Li Q; Ke L
    Exp Ther Med; 2022 Apr; 23(4):307. PubMed ID: 35340870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calmodulin levels in blood cells as a potential biomarker of Alzheimer's disease.
    Esteras N; Alquézar C; de la Encarnación A; Villarejo A; Bermejo-Pareja F; Martín-Requero A
    Alzheimers Res Ther; 2013 Nov; 5(6):55. PubMed ID: 24499616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uncharacterized RNAs in Plasma of Alzheimer's Patients Are Associated with Cognitive Impairment and Show a Potential Diagnostic Power.
    Barbagallo C; Di Martino MT; Grasso M; Salluzzo MG; Scionti F; Cosentino FII; Caruso G; Barbagallo D; Di Pietro C; Ferri R; Caraci F; Purrello M; Ragusa M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum expression of EAAT2 and ADORA2A in patients with different degrees of Alzheimer's disease.
    Meng SX; Wang B; Li WT
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11783-11792. PubMed ID: 33275249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.